Pulse: Industry Perspectives

Balancing conducting patient recruitment with privacy

Tuesday, May 27, 2014

The Pulse on Patient Recruitment by Ashley Tointon

It takes an average of 12 years for a medicine to make it to market and, regardless of the molecule’s Fast Track or Breakthrough Therapy status, the medicine must make it through the rigors of clinical trials before it can be marketed and sold.

[Read More]

Ensuring patient confidentiality during monitoring visits

Monday, May 19, 2014

The Pulse on Study Conduct by Elizabeth Weeks-Rowe

Researchers are ethically bound to preserve the identity and confidentiality of clinical research patients. Patient information must be de-identified to help assure data integrity, prevent bias and achieve an accurate statistical analysis in clinical trials.

[Read More]

Overcoming the myriad challenges of patient enrollment

Monday, April 14, 2014

The Pulse on Site Success by Jeffrey Adelglass

Throughout the evolution of clinical trials, patient enrollment has remained the most confounding element of timely trial completion. From the site perspective, the challenges are many. It is critical to mobilize strategies that minimize cost, maximize recruitment and avert patient attrition.

[Read More]